Cargando…

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility

BACKGROUND: The novel breast cancer metastasis modulator gene signal-induced proliferation-associated 1 (Sipa1) underlies the breast cancer metastasis efficiency modifier locus Mtes 1 and has been shown to influence mammary tumour metastatic efficiency in the mouse, with an ectopically expressing Si...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Szu-Min, Smith, Robert A, Lintell, Nicholas A, Hunter, Kent W, Griffiths, Lyn R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751777/
https://www.ncbi.nlm.nih.gov/pubmed/19765277
http://dx.doi.org/10.1186/1471-2407-9-331
_version_ 1782172259935322112
author Hsieh, Szu-Min
Smith, Robert A
Lintell, Nicholas A
Hunter, Kent W
Griffiths, Lyn R
author_facet Hsieh, Szu-Min
Smith, Robert A
Lintell, Nicholas A
Hunter, Kent W
Griffiths, Lyn R
author_sort Hsieh, Szu-Min
collection PubMed
description BACKGROUND: The novel breast cancer metastasis modulator gene signal-induced proliferation-associated 1 (Sipa1) underlies the breast cancer metastasis efficiency modifier locus Mtes 1 and has been shown to influence mammary tumour metastatic efficiency in the mouse, with an ectopically expressing Sipa1 cell line developing 1.5 to 2 fold more surface pulmonary metastases. Sipa1 encodes a mitogen-inducible GTPase activating (GAP) protein for members of the Ras-related proteins; participates in cell adhesion and modulates mitogen-induced cell cycle progression. Germline SIPA1 SNPs showed association with positive lymph node metastasis and hormonal receptor status in a Caucasian cohort. We hypothesized that SIPA1 may also be correlated to breast carcinoma incidence as well as prognosis. Therefore, this study investigated the potential relationship of SIPA1 and human breast cancer incidence by a germline SNP genotype frequency association study in a case-control Caucasian cohort in Queensland, Australia. METHODS: The SNPs genotyped in this study were identified in a previous study and the genotyping assays were carried out using TaqMan SNP Genotyping Assays. The data were analysed with chi-square method and the Monte Carlo style CLUMP analysis program. RESULTS: Results indicated significance with SIPA1 SNP rs3741378; the CC genotype was more frequently observed in the breast cancer group compared to the disease-free control group, indicating the variant C allele was associated with increased breast cancer incidence. CONCLUSION: This observation indicates SNP rs3741378 as a novel potential sporadic breast cancer predisposition SNP. While it showed association with hormonal receptor status in breast cancer group in a previous pilot study, this exonic missense SNP (Ser (S) to Phe (F)) changes a hydrophilic residue (S) to a hydrophobic residue (F) and may significantly alter the protein functions of SIPA1 in breast tumourgenesis. SIPA1 SNPs rs931127 (5' near gene), and rs746429 (synonymous (Ala (A) to Ala (A)), did not show significant associations with breast cancer incidence, yet were associated with lymph node metastasis in the previous study. This suggests that SIPA1 may be involved in different stages of breast carcinogenesis and since this study replicates a previous study of the associated SNP, it implicates variants of the SIPA1 gene as playing a potential role in breast cancer.
format Text
id pubmed-2751777
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27517772009-09-25 Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility Hsieh, Szu-Min Smith, Robert A Lintell, Nicholas A Hunter, Kent W Griffiths, Lyn R BMC Cancer Research Article BACKGROUND: The novel breast cancer metastasis modulator gene signal-induced proliferation-associated 1 (Sipa1) underlies the breast cancer metastasis efficiency modifier locus Mtes 1 and has been shown to influence mammary tumour metastatic efficiency in the mouse, with an ectopically expressing Sipa1 cell line developing 1.5 to 2 fold more surface pulmonary metastases. Sipa1 encodes a mitogen-inducible GTPase activating (GAP) protein for members of the Ras-related proteins; participates in cell adhesion and modulates mitogen-induced cell cycle progression. Germline SIPA1 SNPs showed association with positive lymph node metastasis and hormonal receptor status in a Caucasian cohort. We hypothesized that SIPA1 may also be correlated to breast carcinoma incidence as well as prognosis. Therefore, this study investigated the potential relationship of SIPA1 and human breast cancer incidence by a germline SNP genotype frequency association study in a case-control Caucasian cohort in Queensland, Australia. METHODS: The SNPs genotyped in this study were identified in a previous study and the genotyping assays were carried out using TaqMan SNP Genotyping Assays. The data were analysed with chi-square method and the Monte Carlo style CLUMP analysis program. RESULTS: Results indicated significance with SIPA1 SNP rs3741378; the CC genotype was more frequently observed in the breast cancer group compared to the disease-free control group, indicating the variant C allele was associated with increased breast cancer incidence. CONCLUSION: This observation indicates SNP rs3741378 as a novel potential sporadic breast cancer predisposition SNP. While it showed association with hormonal receptor status in breast cancer group in a previous pilot study, this exonic missense SNP (Ser (S) to Phe (F)) changes a hydrophilic residue (S) to a hydrophobic residue (F) and may significantly alter the protein functions of SIPA1 in breast tumourgenesis. SIPA1 SNPs rs931127 (5' near gene), and rs746429 (synonymous (Ala (A) to Ala (A)), did not show significant associations with breast cancer incidence, yet were associated with lymph node metastasis in the previous study. This suggests that SIPA1 may be involved in different stages of breast carcinogenesis and since this study replicates a previous study of the associated SNP, it implicates variants of the SIPA1 gene as playing a potential role in breast cancer. BioMed Central 2009-09-18 /pmc/articles/PMC2751777/ /pubmed/19765277 http://dx.doi.org/10.1186/1471-2407-9-331 Text en Copyright ©2009 Hsieh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hsieh, Szu-Min
Smith, Robert A
Lintell, Nicholas A
Hunter, Kent W
Griffiths, Lyn R
Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title_full Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title_fullStr Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title_full_unstemmed Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title_short Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
title_sort polymorphisms of the sipa1 gene and sporadic breast cancer susceptibility
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751777/
https://www.ncbi.nlm.nih.gov/pubmed/19765277
http://dx.doi.org/10.1186/1471-2407-9-331
work_keys_str_mv AT hsiehszumin polymorphismsofthesipa1geneandsporadicbreastcancersusceptibility
AT smithroberta polymorphismsofthesipa1geneandsporadicbreastcancersusceptibility
AT lintellnicholasa polymorphismsofthesipa1geneandsporadicbreastcancersusceptibility
AT hunterkentw polymorphismsofthesipa1geneandsporadicbreastcancersusceptibility
AT griffithslynr polymorphismsofthesipa1geneandsporadicbreastcancersusceptibility